FDA puts hold on Merck multiple myeloma trials after deaths | | (Reuters) - Merck & Co said on Wednesday the U.S. Food and Drug Administration had placed a clinical hold on three multiple myeloma studies testing its Keytruda in combination with other medicines for the blood cancer after more deaths were reported in patients receiving the Merck immunotherapy. |
| |
Heartburn drugs tied to greater mortality | | (Reuters Health) - Widely used heartburn drugs are associated with increased risk of death, and the longer a person uses the drugs, the greater the risk, new research suggests. |
| |
| | |